What
Where
SIRTURO IS BEDAQUILINE, SOLD UNDER THE BRAND NAME SIRTURO, IS A MEDICATION USED TO TREAT ACTIVE TUBERCULOSIS.
(Expired)From: Federal Procurement Data System(Federal)
 Basic Details |  Start Date21 Dec, 2021 (about 2 years ago) Due Date31 Dec, 2021 (about 2 years ago) TypeContractIdentifier75N90022P00093 | ||||
 Customer / Agency | NATIONAL INSTITUTES OF HEALTH | ||||
Unlock the best of InstantMarkets.Please Sign In to see more out of InstantMarkets such as history, intelligent business alerts and many more.
Don't have an account yet? Create a free account now.
SIRTURO IS BEDAQUILINE, SOLD UNDER THE BRAND NAME SIRTURO, IS A MEDICATION USED TO TREAT ACTIVE TUBERCULOSIS.
Solicitation ID/Procurement Identifier: 75N90022P00093
Ultimate Completion Date: Fri Dec 31 18:00:00 GMT
Solicitation ID/Procurement Identifier: 75N90022P00093
Ultimate Completion Date: Fri Dec 31 18:00:00 GMT
Location
Address: TENNESSEE,USA,370863633
Country : United StatesYou may also like
BRAND NAME TRANSFECTION REAGENT (AMBIS #2210343)
Due: 31 May, 2024 (in 1 month)NEW AWARD FOR EMTRICITABINE 200MG/TENOFOVIR DISOPROXIL FUMARATE 300MG TABLETS WITH GSMS. ORDERING PERIOD IS 4/6/2024 TO 4/5/2025 WITH FOUR ONE-YEAR OPTIONS
Due: 05 Apr, 2025 (in 11 months)Please Sign In to see more like these.
Don't have an account yet? Create a free account now.